Dave Muggler

Bio:

Dave Muggler is the Founder and President of PatientSight, a primary research company focused on rare and specialty diseases and patient experience benchmarking. With more than 20 years of work in pharmaceutical Insights & Analytics, Dave has helped companies make better commercial decisions across a wide variety of therapy areas and product lifecycle phases.

Prior to founding PatientSight, Dave held leadership positions with PDI, Syneos Health, and TGaS Advisors (a division of Trinity Life Sciences). This work involved research, analysis, and cross-functional collaboration, leading to development and implementation of commercial solutions for life science companies.

Dave is a thought leader in the emerging field of Patient Experience Benchmarking, an approach that helps life science organizations improve performance in meeting patient needs. He is an author on topics that include rare disease patient research, benchmarking, and the application of AI to survey data.

Driven by a passion for improving health outcomes, Dave founded PatientSight to give patients and caregivers a stronger voice within the life science industry. Today, the company has conducted dozens of studies in rare and specialty therapeutic areas while pioneering new approaches to assessing the patient experience.

Dave and his wife live in Yardley, Pennsylvania, where he enjoys sports, fitness, and family time.